Recurrent Spinal Giant Cell Tumors: A Study of Risk Factors and Recurrence Patterns

다국어 초록 (Multilingual Abstract)

Study Design: Retrospective study.
Purpose: To highlight risk factors, recurrence patterns and multimodal treatment in management of recurrent giant cell tumors (GCTs).
Overview of Literature: GCTs of the spine are rare and challenging entities. Recurrences are very common and warrant complex management to prevent multiple recurrences. Gross total resection is preferred over subtotal procedures to prevent recurrences. However, resection is associated with morbidity and mortality. Proper understanding of risk factors and a high index of suspicion helps to spot recurrences early and aids in subsequent management.
Methods: Ten patients (six females, four males) with recurrent GCTs underwent 17 interventions. There were six lesions in the thoracic spine, two in the cervical spine and two in the lumbar spine. Recurrences were managed with preoperative digital subtraction embolization, intralesional curettage and postoperative radiotherapy.
Results: The average age at intervention was 31.3 years. The average duration of recurrence in patients following index surgery in a tertiary care hospital and surgery elsewhere was 7.3 years and was 40 months, respectively. The minimum recurrence-free interval after the last recurrent surgery was 10 years.
Conclusions: Our study reports the largest recurrence-free interval for GCTs. Recurrent GCTs are challenging entities. Understanding of risk factors and meticulous planning is required to prevent recurrences. Intralesional surgery could be a safer and effective modality in managing recurrences.

참고문헌 (Reference)

1 Yin H, "Treatment and outcome of primary aggressive giant cell tumor in the spine" 24 : 1747-1753, 2015

2 손세일, "The Role of Stereotactic Radiosurgery in Metastasis to the Spine" 대한신경외과학회 51 (51): 1-7, 2012

3 Shikata J, "Surgical treatment of giant-cell tumors of the spine" (278) : 29-36, 1992

4 Fidler MW, "Surgical treatment of giant cell tumours of the thoracic and lumbar spine: report of nine patients" 10 : 69-77, 2001

5 Remedios D, "Radiological and clinical recurrence of giant-cell tumour of bone after the use of cement" 79 : 26-30, 1997

6 Komiya S, "Prognostic factors in giant cell tumor of bone. A modified histological grading system useful as a guide to prognosis" 105 : 67-72, 1986

7 Guzman R, "Preoperative transarterial embolization of vertebral metastases" 14 : 263-268, 2005

8 Nair S, "Preoperative embolization of hypervascular thoracic, lumbar, and sacral spinal column tumors: technique and outcomes from a single center" 19 : 377-385, 2013

9 Fidler MW, "Open transpedicular biopsy of the vertebral body" 72 : 884-885, 1990

10 Roeder F, "Intensity modulated radiotherapy (IMRT) in benign giant cell tumors: a single institution case series and a short review of the literature" 5 : 18-, 2010

11 Hunter CL, "Giantcell tumors of the cervical spine: case report" 59 : E1142-E1143, 2006

12 Sanjay BK, "Giant-cell tumours of the spine" 75 : 148-154, 1993

13 Siebenrock KA, "Giant-cell tumour of bone metastasising to the lungs. A longterm follow-up" 80 : 43-47, 1998

14 Biagini R, "Giant-cell tumor of the spine: a case report" 72 : 1102-1107, 1990

15 Luther N, "Giant cell tumor of the spine" 19 : 49-55, 2008

16 Xu W, "Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center" 20 : 804-810, 2013

17 Mjoberg B, "Bone cement, thermal injury and the radiolucent zone" 55 : 597-600, 1984

18 Hart RA, "A system for surgical staging and management of spine tumors: a clinical outcome study of giant cell tumors of the spine" 22 : 1773-1782, 1997